Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Connective Therapeutics commences phase I/II of TCR vaccine for multiple sclerosis

Jan. 13, 1997

MRC scientists investigate role of somatostatin receptors in the CNS

Jan. 13, 1997

French researcher discloses preventive effects of tryptamine derivatives

Jan. 13, 1997

Titan in-licenses antipsychotic drug from HMR

Jan. 10, 1997

New analgesic agent described by Japanese academics

Jan. 10, 1997

Elan/Scherer Zydis formulation license agreement

Jan. 10, 1997

CCD-1042 progresses in trials

Jan. 9, 1997

High-affinity inhibitor of biogenic amine transporters described

Jan. 9, 1997

Pharmacia & Upjohn describes selective 5-HT2 antagonists

Jan. 9, 1997

New analgesic drug candidate emerges from BioChem Pharma/Astra collaboration

Jan. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...